Clover Health CEO Jamie Reynoso Sells 1,921 Shares

What Happened Jamie L. Reynoso, CEO (Medicare Advantage) of Clover Health Investments (CLOV), sold 1,921 shares in an open-market or private sale on 2026-09-17. The shares were sold at $4.56 per share for a total of $8,760. This was a sale (not a purchase or option exercise).

Key Details

• Transaction date and price: 2026-09-17 — 1,921 shares at $4.56 each.
• Total value: $8,760.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.
• Filing timeliness: Form was filed 2026-09-18 for the 2026-09-17 transaction (filed the next day; not reported as late).

Context

• A sale under a 10b5-1 plan indicates the trade was executed according to a pre-established, rule-compliant plan and is often routine; it does not necessarily signal a change in the insider’s view of the company.
• For retail investors, outright purchases by insiders typically carry more direct interpretive weight than routine sales; this particular transaction is modest in value.